2. "Stat of the Quarter" - 12-Month Allowance Rate of Patent Applications in USPC Class 705 (Business Methods), Biologics and Diagnostic Methods, and the Overall UPR Allowance Rate, Including RCEs The above chart shows a comparison of the 12-month rolling average allowance rate of patent applications in United States Patent Classification (USPC) class 705 (Business Methods), biologics and diagnostic methods, and the overall UPR allowance rate, including RCEs. Note that Biologics and Diagnostics includes USPC classes 435, 506, 530, 536, and 514. 2

3. Monthly Allowance Rate of Patent Applications in USPC Class 705 (Business Methods), Biologics and Diagnostic Methods, and the Overall UPR Allowance Rate, Including RCEs The recent decline in the allowance rate includes the withdrawal of approximately 1,200 applications in USPC class 705 that were withdrawn from allowance immediately following the Supreme Court’s decision in Alice Corp. These applications required new grounds of rejection(s) under 35 USC 101 to be consistent with the Alice Corp. decision, and included applications that were indicated as allowable prior to the Alice Corp. decision, but that had not yet issued as patents. The decline in the allowance rate appears prior to the date of the Alice Corp. decision due to the withdrawn applications that were indicated as allowable prior to Alice Corp. Additionally, it should be noted that the allowance rate in USPC class 705 is still in flux given the new grounds of rejection(s) that were entered in previously allowed applications, as well as in previously rejected applications. 3